|
|
||||||||
1Departments of Physiology and Internal Medicine, University of Manitoba, Winnipeg; 2Biology of Breathing Group, Manitoba Institute of Child Health, Winnipeg; 3Department of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands; 4Flow Cytometry Laboratory, University of Manitoba, Winnipeg; 5Escola Superior de Tecnologia da Saúde de Lisbon, Lisbon, Portugal; 6Department of Pharmacology, University of Nevada School of Medicine, Reno, Nevada; 7Section of Thoracic Surgery, University of Manitoba, Winnipeg, Manitoba, Canada
Submitted 23 August 2007 ; accepted in final form 8 September 2007
Muscarinic receptors and platelet-derived growth factor (PDGF) receptors synergistically induce proliferation of airway smooth muscle (ASM), but the pathways that regulate these effects are not yet completely identified. We hypothesized that glycogen synthase kinase-3 (GSK-3), a kinase that represses several promitogenic signaling pathways in its unphosphorylated form, is cooperatively inhibited by PDGF and muscarinic receptors in immortalized human ASM cell lines. PDGF or methacholine alone induced rapid GSK-3 phosphorylation. This phosphorylation was sustained only for PDGF; however, methacholine potentiated PDGF-induced sustained GSK-3 phosphorylation. Synergistic effects of methacholine also were observed on PDGF-induced retinoblastoma protein (Rb) phosphorylation and cell proliferation. Suppression of GSK-3 inhibitory function using SB 216763 also augmented PDGF-induced Rb phosphorylation and cell cycle progression; this synergy was similar in magnitude to that seen for methacholine with PDGF. GSK-3 phosphorylation induced by methacholine required PKC, since it was abolished by GF 109203X and Gö 6976; however, inhibition of PKC had no effect on cell responses to PDGF. PKC inhibition also specifically abolished the synergistic effect of methacholine on PDGF-induced GSK-3 phosphorylation and cell proliferation. Collectively, these results show that GSK-3 plays a key repressive role in ASM cell proliferation. Moreover, muscarinic receptors mediate PKC-dependent GSK-3 inhibition, and this appears to be a primary mechanism underpinning augmentation of PDGF-induced cell growth.
asthma; airway hyperresponsiveness; cell cycle; G protein-coupled receptor; airway remodeling
This article has been cited by other articles:
![]() |
J. K. Bentley, H. Deng, M. J. Linn, J. Lei, G. A. Dokshin, D. C. Fingar, K. N. Bitar, W. R. Henderson Jr., and M. B. Hershenson Airway smooth muscle hyperplasia and hypertrophy correlate with glycogen synthase kinase-3{beta} phosphorylation in a mouse model of asthma Am J Physiol Lung Cell Mol Physiol, February 1, 2009; 296(2): L176 - L184. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Meurs, R. Gosens, and J. Zaagsma Airway hyperresponsiveness in asthma: lessons from in vitro model systems and animal models Eur. Respir. J., August 1, 2008; 32(2): 487 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. O. Nunes, M. Schmidt, G. Dueck, H. Baarsma, A. J. Halayko, H. A. M. Kerstjens, H. Meurs, and R. Gosens GSK-3/{beta}-catenin signaling axis in airway smooth muscle: role in mitogenic signaling Am J Physiol Lung Cell Mol Physiol, June 1, 2008; 294(6): L1110 - L1118. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |